Table 1.
Baseline characteristics of cirrhotic patients
| Demographics | Median QFM (95%CI) IU/mL | |
| Age (median, yr) | 54 (20-72) | 94.5 (37.3-158) |
| Male | 62 (68.1%) | 124.5 (37.3-223) |
| Female | 29 (31.9%) | 73.9 (7.50-158) |
| Child-Pugh score | ||
| A | 7 | 381 (12.9-1234) |
| B | 29 | 224 (94.4-506) |
| C | 55 | 37.3 (19.5-128) |
| MELD score | ||
| 0-10 | 10 | 319 (12.9-904) |
| 11-20 | 42 | 155.5 (94.5-240) |
| 21-30 | 34 | 30.0 (9.16-157) |
| ≥ 30 | 5 | 8.81 (0.63-47.6) |
| Primary aetiology of cirrhosis, n (%) | ||
| HCV | 39 (42.9) | 130 (47.6-223) |
| PSC | 10 (11.0) | 61.6 (1.19-279) |
| ETOH | 10 (11.0) | 113.3 (8.81-385) |
| NASH | 9 (9.89) | 20.3 (6.20-375) |
| AIH | 5 (5.49) | 37.3 (0.04-137) |
| PBC | 4 (4.40) | 93.0 (24.1-168) |
| HBV | 3 (3.30) | 904 (799-1132) |
| Retransplant | 3 (3.30) | 163 (2.06-318) |
| Other | 8 (8.79) | 6.59 (0.07-774) |
| HCC | 31 (34.1) | 194 (87.9-425) |
| No HCC | 61 (65.9) | 73.9 (28.0-154) |
QFM: QuantiFERON-Monitor; HCV: Hepatitis C virus; PSC: Primary sclerosing cholangitis; ETOH: Alcohol; NASH: Non-alcoholic steatohepatitis; AIH: Autoimmune hepatitis; PBC: Primary biliary cirrhosis; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma.